AnalystsIan SomaiyaIan Somaiya's Stock Forecasts
AnalystsIan Somaiya
Analyst Ranking
Top 23%
#1034 out of 4560 analysts
Average Return
+5.78%
Win Rate
43%22 out of 51
Risk vs Reward
Poor
Good
Ian Somaiya's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Ra Pharmaceuticals IncRARX | +295.64% | $6.88 | $27.22 | 2018-03-14 - 2019-03-15 | Buy |
Ra Pharmaceuticals IncRARX | +200.18% | $11.17 | $33.53 | 2018-07-19 - 2019-07-19 | Buy |
Avexis IncAVXS | +109.41% | $104.02 | $217.83 | 2017-10-11 - 2018-05-15 | Buy |
Galapagos NvGLPG | +86.02% | $99.55 | $185.18 | 2018-10-29 - 2019-10-30 | Strong Buy |
Intercept Pharmaceuticals IncICPT | +85.37% | $61.59 | $114.17 | 2017-09-21 - 2018-09-21 | Buy |
Ian Somaiya Analyst Color
Get additional color on Ian Somaiya's coverage of popular stocks
Ian Somaiya's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Amgen IncAMGN | 4 | Buy | $228.00 | N/A | Initiates Coverage On | 5 years ago |
Gilead Sciences IncGILD | 2 | Buy | $78.00 | N/A | Initiates Coverage On | 5 years ago |
Biogen IncBIIB | 3 | Hold | $322.00 | N/A | Initiates Coverage On | 5 years ago |
Myokardia IncMYOK | 2 | Buy | $85.00 | N/A | Initiates Coverage On | 5 years ago |
Protagonist Therapeutics IncPTGX | 5 | Buy | $17.00 | N/A | Initiates Coverage On | 5 years ago |
Galapagos NvGLPG | 3 | Strong Buy | $140.00 | N/A | Maintains | 5 years ago |
Ra Pharmaceuticals IncRARX | 2 | Buy | $20.00 | N/A | Initiates Coverage On | 6 years ago |
Spyre Therapeutics IncSYRE | 2 | Buy | $525.00 | N/A | Initiates Coverage On | 6 years ago |
Obseva SaOBSVF | 2 | Buy | $23.00 | N/A | Initiates Coverage On | 6 years ago |
Tetraphase Pharmaceuticals IncTTPH | 5 | Hold | $3.00 | N/A | Maintains | 6 years ago |
Five Prime Therapeutics IncFPRX | 3 | Buy | $60.00 | N/A | Maintains | 6 years ago |
Celgene CorpCELG | 5 | Buy | $139.00 | N/A | Maintains | 6 years ago |
Avexis IncAVXS | 2 | Buy | $148.00 | N/A | Maintains | 6 years ago |
Biomarin Pharmaceutical IncBMRN | 2 | Buy | $125.00 | N/A | Maintains | 6 years ago |
Intercept Pharmaceuticals IncICPT | 3 | Buy | $155.00 | N/A | Maintains | 6 years ago |
Alexion Pharmaceuticals IncALXN | 5 | Buy | $180.00 | N/A | Maintains | 6 years ago |
Inflarx NvIFRX | 1 | Buy | $31.00 | N/A | Initiates Coverage On | 6 years ago |
Neurocrine Biosciences IncNBIX | 1 | Buy | $109.00 | N/A | Maintains | 6 years ago |
Incyte CorpINCY | 4 | Buy | $166.00 | N/A | Maintains | 6 years ago |
Coherus Biosciences IncCHRS | 1 | Buy | $54.00 | N/A | Initiates Coverage On | 7 years ago |
Oncomed Pharmaceuticals IncOMED | 1 | Hold | $6.00 | N/A | Downgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.